Rainbow BioSciences, LLC Signs Letter of Intent with Cutting-Edge Biosciences Firm

December 12, 2011 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

NOKOMIS, Fla.--(BUSINESS WIRE)--Rainbow Biosciences, a division of Rainbow Coral Corp. (OTCBB:RBCC) announced today that it signed a letter of intent to acquire or form a new joint venture with cutting-edge biotech firm n3D Biosciences, Inc. (n3D).

Twitter
LinkedIn
Facebook
Email
Print

Alliances